⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL210495 | 0.81 | — | — | |
| SCHEMBL746126 | 0.75 | — | — | |
| SCHEMBL4831678 | 0.72 | — | — | |
| SCHEMBL4370451 | 0.72 | — | — | |
| SCHEMBL7698086 | 0.72 | — | — | |
| SCHEMBL426680 | 0.72 | — | — | |
| SCHEMBL1465655 | 0.72 | — | — | |
| SCHEMBL714052 | 0.71 | MEN1 (0.39) | — | |
| SCHEMBL2986917 | 0.71 | — | — | |
| SCHEMBL619635 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7173060-B2 | Oxime derivatives and their use as pharmaceutically active agents | HOFFMANN-LA ROCHE INC. | 2007-02-06 | — | — | US | disclosed |
| EP-1613622-A1 | OXIME DERIVATIVES AND THEIR USE AS PHARMACEUTICALLY ACTIVE AGENTS | F. HOFFMANN-LA ROCHE AG (CH) | 2006-01-11 | — | — | EP | disclosed |
| US-20040214880-A1 | Oxime derivatives and their use as pharmaceutically active agents | HOFFMANN-LA ROCHE INC. | 2004-10-28 | — | — | US | disclosed |
| WO-2004087693-A1 | OXIME DERIVATIVES AND THEIR USE AS PHARMACEUTICALLY ACTIVE AGENTS | F. HOFFMANN-LA ROCHE AG (CH) | 2004-10-14 | — | — | WO | disclosed |